Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice.
about
Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosisCharacterization of the rodent genes for arylacetamide deacetylase, a putative microsomal lipase, and evidence for transcriptional regulationSorting out the roles of PPAR alpha in energy metabolism and vascular homeostasisGrowth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)Nuclear receptor corepressor RIP140 regulates fat accumulationPeroxisome proliferator-activated receptor alpha mediates the adaptive response to fastingIs peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?Nutritional and Hormonal Regulation of Citrate and Carnitine/Acylcarnitine Transporters: Two Mitochondrial Carriers Involved in Fatty Acid MetabolismRole of BAF60a/BAF60c in chromatin remodeling and hepatic lipid metabolismOrphan nuclear receptors and the regulation of nutrient metabolism: understanding obesityHuman sterol 27-hydroxylase (CYP27) overexpressor transgenic mouse model. Evidence against 27-hydroxycholesterol as a critical regulator of cholesterol homeostasisEvidence that peroxisome proliferator-activated receptor alpha is complexed with the 90-kDa heat shock protein and the hepatitis virus B X-associated protein 2Fatty-acyl-CoA thioesters inhibit recruitment of steroid receptor co-activator 1 to alpha and gamma isoforms of peroxisome-proliferator-activated receptors by competing with agonistsLong-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor alpha (PPARalpha)-independent pathwayPPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null miceActivation of peroxisome proliferator-activated receptor alpha increases the expression and activity of microsomal triglyceride transfer protein in the liverPPARs in obesity-induced T2DM, dyslipidaemia and NAFLD.Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in miceLiver fatty acid-binding protein targets fatty acids to the nucleus. Real time confocal and multiphoton fluorescence imaging in living cells.A potent PPARalpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle.Gene expression profiles in fathead minnow exposed to 2,4-DNT: correlation with toxicity in mammals.Transcriptional Regulation of the Mitochondrial Citrate and Carnitine/Acylcarnitine Transporters: Two Genes Involved in Fatty Acid Biosynthesis and β-oxidation.Microgram-order ammonium perfluorooctanoate may activate mouse peroxisome proliferator-activated receptor alpha, but not human PPARalpha.Relative gene expression of fatty acid synthesis genes at 60 days postpartum in bovine mammary epithelial cells of Surti and Jafarabadi buffaloesMetabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic miceDiscovering networks of perturbed biological processes in hepatocyte culturesEffect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia.Long chain acyl-CoA synthetase-3 is a molecular target for peroxisome proliferator-activated receptor delta in HepG2 hepatoma cells.Regulation of lipid and lipoprotein metabolism by PPAR activators.Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver.Orphan nuclear hormone receptor Rev-erbalpha regulates the human apolipoprotein CIII promoter.PPARα in Obesity: Sex Difference and Estrogen Involvement.PPARγ-induced cardiolipotoxicity in mice is ameliorated by PPARα deficiency despite increases in fatty acid oxidation.Hepatic trans-Golgi action coordinated by the GTPase ARFRP1 is crucial for lipoprotein lipidation and assembly.Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor.Peroxisome proliferator-activated receptor delta promotes very low-density lipoprotein-derived fatty acid catabolism in the macrophageCurrent practice in the treatment of hyperlipidaemias.In vivo activation of PPAR target genes by RXR homodimers.Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor alpha mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytesPerfluoroalkyl acids: a review of monitoring and toxicological findings.
P2860
Q22004166-9B26B338-2A69-42FA-99AB-863C6AA3F367Q24291501-A033F5AA-799C-4458-87B2-8318A5E1CDBCQ24541529-F81EC6AB-1178-4E9F-B07E-7E2C7AE1672CQ24553125-ECAA53D4-4FEE-45C3-AF60-1E4ED9385F3FQ24561531-B72E37BA-290E-4EDC-8180-4CC14C7CE6B3Q24563197-49BC350E-A810-449A-94B0-A403865120E7Q24812167-D2F6EE2D-5D8C-4674-906F-3B83731C72EDQ26745573-048C2E75-2A1F-40F9-BAA7-00AEB8EC989BQ26749020-CEA73D79-7578-44BB-B6BF-F85D60BC73D8Q26823819-0BAB3A4D-AA04-49F5-96B4-A990285467D4Q28214768-D3CB44C7-B5E9-4DE0-B2C4-7A4A3776FFE5Q28217612-585FE3A9-0531-4A7C-AC37-D198952A5A2BQ28345513-6B998F52-68C5-4C18-90EC-033C3527F651Q28348167-E3B347B5-ED75-46D1-8562-98D78D0EB979Q28362804-E2A22C75-E37A-488C-B384-A81AE8F0DF58Q28570588-6CD3D36E-C1A8-463F-950C-5323D15D71C7Q30241952-A0291D69-EC1F-4802-A05D-D73521C89DFAQ30513404-5A0AEB73-C427-4A18-8C91-C5C0E4E0BF02Q31060634-B580910A-5C7A-4A38-8C6E-F59277D90CC0Q31833512-39B76276-2FE1-4CD2-8F83-0573F88A6FCCQ33254375-93ACE7B2-7BB6-4244-AF5D-132B1F4D1D15Q33565455-E5165BDB-A02A-4C45-BF7D-7C7C94FE6DA4Q33764873-FE3AAC71-BA73-4C51-98B0-1572981CBB61Q33782099-B275FD08-933C-4CD5-BEBA-FE121B89B755Q33782682-95464DF1-D75F-48A0-9BF4-07FE2C3DD91CQ33796560-02D7AC03-FF31-4084-9E2E-4B739EA59D5BQ33876924-CB13CE63-98C8-4425-8F35-6E98AA950799Q33883373-3C2B8732-15A0-45AD-B9C3-464FCD339F69Q33896369-EC28B551-8E78-4471-85BD-B8E1778344DBQ33964008-CF2192CF-DF03-475B-90E1-F5E630A352B5Q34129395-B83D8429-F587-4610-8F22-06112697097DQ34143769-586B95E4-7401-4906-BAEC-C51C13B675D5Q34162103-5CE03967-D3A4-4B4F-861C-B028A7833E42Q34382248-5B746E26-6A9F-4FF9-9510-C89BFFE5F546Q34479025-44730698-9CC1-4B91-9273-2E2E7210DF6CQ34479176-4CD13717-A779-4E47-8D7B-641C117F9028Q34515467-9D1A079A-C36A-4470-A3B6-74B886A97E4BQ34569879-24A789C7-7FBB-4B09-ADCC-ACA170849AE8Q34591652-030B761B-8824-4A29-8256-02D97FD57379Q34630884-BA459415-44CA-4314-91E8-563F54DA08C0
P2860
Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Alterations in lipoprotein met ...... receptor alpha-deficient mice.
@en
Alterations in lipoprotein met ...... receptor alpha-deficient mice.
@nl
type
label
Alterations in lipoprotein met ...... receptor alpha-deficient mice.
@en
Alterations in lipoprotein met ...... receptor alpha-deficient mice.
@nl
prefLabel
Alterations in lipoprotein met ...... receptor alpha-deficient mice.
@en
Alterations in lipoprotein met ...... receptor alpha-deficient mice.
@nl
P2093
P356
P1476
Alterations in lipoprotein met ...... receptor alpha-deficient mice.
@en
P2093
Fruchart JC
Gonzalez FJ
Hennuyer N
P304
27307-27312
P356
10.1074/JBC.272.43.27307
P407
P577
1997-10-01T00:00:00Z